Drug Trial Radar · NCT07409428
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Mar 20, 2026
Primary completion
Apr 30, 2028
Study completion Dec 30, 2028
Sponsor
- Lead sponsor
- HutchmedIndustry
- Sponsor type
- Industry
- First posted
- Feb 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III randomized, double-blind, positive controlled study to evaluate the efficacy, safety, and pharmacokinetics of HMPL-760 in combination with R-GemOx versus placebo in combination with R-GemOx in patients with R/R DLBCL.
Conditions
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Interventions
HMPL-760Drug
Patients will receive HMPL-760 once daily (QD) orally.
HMPL-760 PlaceboDrug
Patients will receive HMPL-760 placebo once daily (QD) orally.
R-GemOxDrug
R-GemOx regimen in 21-day cycles for a total of 8 cycles. Rituximab 375 mg/m2 IV is given on Day 1 of each cycle, and gemcitabine 1000 mg/m2 IV followed by oxaliplatin 100 mg/m2 IV is given on Day 2 of each cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: Up to approximately two years
- End of treatment (EOT)Time frame: Up to approximately two years
- Systemic antitumor therapyTime frame: Up to approximately two years
- Overall survival (OS)Time frame: Up to approximately two years
- systematic anti-tumor therapyTime frame: Up to approximately two years
- Premature withdrawal from study treatmentTime frame: Up to approximately two years
Locations
51 sites in 1 country. Site status is shown where the registry gives one.
Baoding NO.1 Central Hospital
Baoding, China · Recruiting
Beijing GoBroad Hospital
Beijing, China · Recruiting
BEIJING TONGREN HOSPITAL, Capital Medical University
Beijing, China · Recruiting
The First Affiliated Hospital of Bengbu Medical College
Bengbu, China · Recruiting
The First Hospital of Jilin University
Changchun, China · Recruiting
Hunan Cancer Hospital
Changsha, China · Recruiting
People's Hospital of Hunan Province
Changsha, China · Recruiting
The Second Xiangya Hospital of Central South University
Changsha, China · Recruiting
Sichuan Provincial People's Hospital
Chengdu, China · Recruiting
West China Hospital of Sichuan University
Chengdu, China · Recruiting
Chongqing University Cancer Hospital
Chongqing, China · Recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China · Recruiting
Quanzhou First Hospital.Fujian
Fujian, China · Recruiting
Fujian Medical University Union Hospital
Fuzhou, China · Recruiting
Guangdong Provincial People's Hospital
Guangzhou, China · Recruiting
Sun Yat-sen University Cancer Center
Guangzhou, China · Recruiting
ZhuJiang Hospital of Southern Medical University(The Second Clinical Medical College)
Guangzhou, China · Recruiting
The Affiliated Hospital of Guizhou Medical University
Guiyang, China · Recruiting
The First Affiliated Hospital, Zhejiang University
Hangzhou, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, China · Recruiting
Harbin Medical University Cancer Hospital
Harbin, China · Recruiting
The Second Affiliated Hospital of Anhui Medical University
Hefei, China · Recruiting
Qilu Hospital of Shandong University
Jinan, China · Recruiting
Shandong Cancer Hospital & Institute
Jinan, China · Recruiting
The First Affiliated Hospital of Kunming Medical University
Kunming, China · Not yet recruiting
Jiangxi Cancer Hospital
Nanchang, China · Recruiting
Jiangsu Cancer Hospital
Nanjing, China · Recruiting
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Nanjing, China · Recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, China · Recruiting
The Affiliated Hospital of Qingdao University
Qingdao, China · Recruiting
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China · Recruiting
Tong Ren Hospital Shanghai Jiao Tong University School Of Medicine
Shanghai, China · Not yet recruiting
Tongji Hospital of Tongji University
Shanghai, China · Recruiting
Shengjing Hospital of China Medical University
Shenyang, China · Recruiting
Shenzhen people's hospital
Shenzhen, China · Recruiting
Shanxi Provincial Cancer Hospital
Taiyuan, China · Recruiting
North China University of Science and Technology Affiliated Hospital
Tangshan, China · Recruiting
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Tianjin, China · Recruiting
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China · Recruiting
Tianjin People's Hospital
Tianjin, China · Recruiting
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.